Altium Capital Management LP Verona Pharma PLC Transaction History

Altium Capital Management LP

  • $283 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$18.06 - $25.27 $3.43 Million - $4.8 Million
-190,000 Reduced 88.37%
25,000 $501,000
Q4 2022

Feb 14, 2023
SELL
$9.84 - $26.13 $1.86 Million - $4.94 Million
-189,000 Reduced 46.78%
215,000 $5.62 Million
Q3 2022

Nov 14, 2022
BUY
$4.14 - $13.59 $1.67 Million - $5.49 Million
404,000 New
404,000 $4.13 Million

Others Institutions Holding VRNA

# of Institutions
167
Shares Held
68.7M
Call Options Held
704K
Put Options Held
685K
View Full List

About Verona Pharma plc

VRNA Quotes by TradingView
  • Ticker VRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,954,200
  • Market Cap $2.84B
  • Description
  • Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...
More about VRNA
Track This Portfolio

Track Altium Capital Management LP Portfolio

Follow Altium Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Altium Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Altium Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email